Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,218 public trials 94 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00516828

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +6 more
Locations
  • QEII Health Sciences Center Halifax, Nova Scotia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University - Dept. Oncology Montreal, Quebec, Canada
View Trial Details
Completed

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

NCT00046930

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 92 locations
View Trial Details
Completed

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

NCT00074282

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 143 locations
View Trial Details
Completed

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

NCT00045305

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Tufts-NEMC Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

NCT00005962

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 65 locations
View Trial Details
Completed

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00006390

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Completed

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

NCT00002868

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States
  • Royal Infirmary Glasgow, Scotland, United Kingdom
View Trial Details
Completed

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00003808

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Beckman Research Institute, City of Hope Los Angeles, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 71 locations
View Trial Details

Related conditions